Cargando…
肺移植术后闭塞性细支气管炎综合征预测标记物研究进展
Lung transplantation is the ultimate treatment of end-stage lung disease. After transplantation, the 1-year survival rate is 80%, while the 5-year survival rates remaines at around 50% mainly due to bronchiolitis obliterans syndrome (BOS). BOS is regarded as a fibrosing process in the small airways...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309540/ https://www.ncbi.nlm.nih.gov/pubmed/32517455 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.03 |